Su1577 UNRAVELING MECHANISMS OF HEPATIC INVOLVEMENT IN DISORDERS WITH IMPAIRED INSULIN SIGNALING: A PROTEOMIC ANALYSIS.
Maria Mironova(National Institutes of Health), Rebecca J. Brown(National Institutes of Health), Yaron Rotman(National Institute of Diabetes and Digestive and Kidney Diseases), Allison Wing(Yale University)
Cited by 0
Related Papers
JAK1/2 inhibition with baricitinib in the treatment of autoinflammatory interferonopathies
|Journal of Clinical Investigation|2018|519
Natural Killer Cells Are Polarized Toward Cytotoxicity in Chronic Hepatitis C in an Interferon-Alfa–Dependent Manner
|Gastroenterology|2009|271
The liver diseases of lipodystrophy: The long-term effect of leptin treatment
|Journal of Hepatology|2013|165
Anti-modified LDL antibodies, LDL-containing immune complexes, and susceptibility of LDL to in vitro oxidation in patients with type 2 diabetes.
|Diabetes|2000|97
Characterization of essential domains in HSD17B13 for cellular localization and enzymatic activity
|Journal of Lipid Research|2020|27